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Studies have suggested that exposure to ultraviolet (UV) light may increase risk of herpes simplex virus (HSV)
recurrence. Between 1993 and 1997, the Herpetic Eye Disease Study (HEDS) randomized 703 participants with
ocular HSV to receipt of acyclovir or placebo for prevention of ocular HSV recurrence. Of these, 308 HEDS partic-
ipants (48% female and 85% white; median age, 49 years) were included in a nested study of exposures thought to
cause recurrence and were followed for up to 15 months. We matched weekly UV index values from the National
Oceanic and Atmospheric Administration to each participant’s study center and used marginal structural Cox mod-
els to account for time-varying psychological stress and contact lens use and selection bias from dropout. There
were 44 recurrences of ocular HSV, yielding an incidence of 4.3 events per 1,000 person-weeks. Weighted hazard
ratios comparing persons with ≥8 hours of time outdoors to those with less exposure were 0.84 (95% confidence
interval (CI): 0.27, 2.63) and 3.10 (95% CI: 1.14, 8.48) for weeks with a UV index of <4 and ≥4, respectively (ratio of
hazard ratios = 3.68, 95% CI: 0.43, 31.4). Though results were imprecise, when the UV index was higher (i.e., ≥4),
spending 8 or more hours per week outdoors was associated with increased risk of ocular HSV recurrence.
cohort studies; herpes simplex virus; recurrence; sunlight; ultraviolet light; UV index
Abbreviations: CI, confidence interval; HEDS, Herpetic Eye Disease Study; HSV, herpes simplex virus; UV, ultraviolet.
Approximately 70% of the US population is seropositive
for herpes simplex virus (HSV) type 1 or 2 (1). After initial
infection, HSV becomes latent in neuronal cell bodies, in-
cluding those affecting the eye, but it can be reactivated, re-
sulting in recurring eruptive lesions. Ocular HSV lesions can
cause corneal scarring, and recurrent ocular HSV infections
are a leading cause of vision loss (2, 3). Antiviral treatment is
available for ocular HSV disease; in more severe cases, phy-
sicians may recommend prophylactic treatment to prevent re-
currences (4, 5). However, prophylaxis may not be entirely
effective, making it essential to understand and intervene
with regard to the causes of ocular recurrence.
Exposure to ultraviolet (UV) B light has been used in an-
imal models to induce recurrences of HSV infection (6, 7)
and to induce recurrences of orofacial HSV in humans (8,
9). However, the existing literature regarding the association
between season (10–16) or sunlight exposure (17, 18) and
ocular HSV recurrence remains inadequate to inform preven-
tive interventions on limiting exposure to UV light. Previous
studies have largely based measures of UV exposure on self-
reports (17), typically reports of the number of hours spent
outdoors each week; however, this measure does not account
for seasonal and weather-related variation in UV levels.
Investigators in the Herpetic Eye Disease Study (HEDS)
prospectively followed participants with ocular HSV for 15
months and found that participants exposed to more than
21 hours of sunlight per week experienced 1.93 times the
rate of ocular HSV recurrence as those exposed to ≤21 hours,
although results were imprecise, with a nearly 10-fold wide
confidence interval (95% confidence interval (CI): 0.68,
5.49) (17). The HEDS analysis did not adequately control for
confounding by time-varying factors, such as psychological
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stress. Psychological stress might be a time-varying con-
founder because psychological stress 1) may be an indepen-
dent predictor of recurrence (19) and 2) may be affected by
prior UV exposure (20–22). Moreover, there may be feed-
back between psychological stress and UV exposure given
that the number of hours spent outdoors each week may be
associated with prior level of psychological stress. Simply
using time-updated reports of sunlight exposure and includ-
ing confounders in standard regressionmodels does not allow
for possible feedback between time-varying UV exposure
and confounder levels (23). If there are time-varying con-
founders that are affected by prior sunlight exposure, then
standard analytical methods (e.g., restriction, stratification,
regression) fail to estimate the total (i.e., direct and indirect)
effect of UV exposure on the risk of HSV recurrence. Regres-
sion adjustment blocks effects of UV exposure mediated
through psychological stress, a possible time-varying con-
founder, as well as induces possible collider-conditioning
bias (24). Marginal structural models can be used to obtain
asymptotically consistent estimates of the total effect of UV
exposure on ocular HSV recurrence in the presence of time-
varying confounding (25–27).
We used weekly prospective data on self-reported hours of
sunlight exposure, UV index measurements from the Na-
tional Oceanic and Atmospheric Administration, physician-
documentedHSVrecurrences, andmarginal structuralmodels
to estimate the total effect of unprotected UV exposure on oc-
ular HSV recurrence.
MATERIALS AND METHODS
Herpetic Eye Disease Study
The HEDS enrolled 703 persons in a placebo-controlled
randomized trial assessing the prophylactic effect of 500 mg
of acyclovir administered orally twice daily on ocular HSV
recurrence (28). Participants were immunocompetent per-
sons aged 12 years or older who had a documented history
of ocular HSV recurrence during the prior year, with no ac-
tive disease in the month prior to study entry. They were en-
rolled at 74 US clinical sites between 1992 and 1996. Of the
703 eligible participants, 308 volunteered to enroll in a nested
cohort study to assess potential triggers of ocular HSV recur-
rence (17). Participants in this nested cohort study filled out
weekly reports of the past week’s exposures, including un-
protected time spent outdoors and psychological stress. To
avoid the recall bias shown to be present in this cohort (29)
and decrease misreports, we excluded from this analysis
weekly forms that had been completed more than 2 days be-
fore the end of the week or more than 3 days after the end of
the week (1,850 forms) or that were missing the date of com-
pletion (320 forms). Participants were followed from study
entry to the first documented recurrence of ocular HSV or were
censored at the end of study follow-up (15 months) or at the
third week of missing data, regardless of whether weekly re-
ports were resumed (i.e., dropout).
The parent study protocol and informed consent forms
were approved by the institutional review boards at the partic-
ipating sites, and all participants provided written informed
consent. Our analysis protocol was reviewed by the Uni-
versity of North Carolina Biomedical Institutional Review
Board.
Ascertainment of HSV recurrences
Recurrence of ocular HSV was ascertained by a study-
certified ophthalmologist using slit-lamp biomicroscopy at
clinical examinations performed during months 1, 3, 6, 9,
12, 13, and 15 after randomization, and at additional times
when participants reported new ocular symptoms. Dates of
recurrence were recorded, and analyses were conducted for
the first recurrence of ocular HSV after enrollment.
Assessment of sunlight exposure, covariates, and
UV index
Weekly forms completed by participants were used to
measure self-reported number of hours spent outdoors each
week. Participants responded to the question, “In the past
week, approximately how many total hours did you spend
outdoors unprotected by a brimmed hat or other protective
clothing?” Response categories were ≤7 hours, 8–14 hours,
15–21 hours, 22–28 hours, and ≥29 hours.
Data on age (in years), gender, race/ethnicity (self-
reported; included in this study as white or other), study region,
and numbers of self-reported prior ocular and nonocular HSV
recurrences were collected at the first study visit. Weekly re-
ports included information about use of contact lenses, regu-
lar use of glasses or sunglasses, and psychological stress.
Psychological stress was recorded by the participants weekly
using a global stress scale (30), where participants responded
on a 7-point Likert scale to the question, “How stressed did
you feel in the past week?” (1 = not at all stressed, 7 =
extremely stressed). Because study personnel collected data
at the first trial visit, there were no missing data for time-
fixed variables. When information on contact lens use (21%
missing), psychological stress (25% missing), and time spent
outdoors (24% missing) was missing at baseline, these vari-
ables were set to studywide median values; in the weeks fol-
lowing baseline, the previous week’s covariate and exposure
data were carried forward for a maximum of 3 weeks when
weekly reports were missing. Of the 9,855 weeks after base-
line included in the study, 20% of information on contact lens
use was carried forward, 21% of information on psycholog-
ical stress was carried forward, and 20% of information on
time spent outdoors was carried forward.
Daily UV index data for at least 1 city per state became
publicly available through the National Oceanic and Atmo-
spheric Administration beginning in January 1994. UV indi-
ces represent UV exposure predicted by a computer model
that relates atmospheric ozone levels to UV incidence on
the ground, forecasted cloud coverage, and elevation (31).
Participants were assigned weekly averaged UV index values
corresponding to the city closest to the clinical site they vis-
ited. For study dates prior to January 1994 (8% of weeks), the
UV index was multiply imputed (32, 33) 30 times, assuming
that the UV index values were missing at random given the
month of the year, daily values for precipitation, minimum
temperature, maximum temperature, average temperature,
and cloud cover, and ocular recurrences (34).
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Statistical analysis
Time spent outdoors was dichotomized into 2 groups—≤7
hours per week and ≥8 hours per week—because of the rel-
atively small number of ocular recurrences (for the full distri-
bution, see Web Table 1, available at http://aje.oxfordjournals.
org/). According to World Health Organization reporting
guidelines (35), UV index values of ≤2, 3–5, 6–7, 8–10,
and ≥11 are considered to represent low, moderate, high,
very high, and extreme risk, respectively. Protective clothing,
including long sleeves, sunglasses, and a hat, is recommended
for days when the UV index is 3 or higher, and sunscreen is
recommended for days when the UV index is 6 or higher
(31). The median UV index during the week prior to an oc-
ular HSV recurrencewas 4; we dichotomized the UV index at
4 (<4 vs. ≥4) to enhance precision.
Absolute incidence differences were estimated using addi-
tive Poisson regression (36). Hazard ratios were estimated
using Cox proportional hazards models (37) with time in the
study as the time scale and Efron’s approximation for tied
event times (38). Inferences from all 30 multiple imputations
were combined using Rubin’s multiple imputation formula
(32). Wald-type 95% confidence intervals were estimated
using the standard large-sample approximation for variance
in the crude models and the robust variance for weighted
models (27). We tested the proportional hazards assumption
by computing the slope and variance of the Schoenfeld resid-
uals and combining these values over the 30 imputations
using Rubin’s multiple imputation formula (32). AWald test
of the slope being equal to 0 (proportional hazards) was con-
sidered significant at the P < 0.10 level.
Observed data were weighted by the product of stabilized
inverse probability-of-exposure-and-dropout weights to ac-
count for confounding and selection bias by measured char-
acteristics. Dichotomized measures of hours spent outdoors
and dropout were modeled using standard pooled logistic
models (39). Candidate confounders included age, gender,
race/ethnicity, number of prior ocular recurrences, number
of prior nonocular recurrences, psychological stress, use of
glasses or sunglasses, and use of contact lenses. Randomiza-
tion assignment was not considered as a confounder because
it was not thought to be associated with time spent outdoors.
Not included as confounders in the final weight model were
race/ethnicity, number of prior recurrences of ocular HSV,
number of prior recurrences of nonocular HSV, and use of
glasses or sunglasses, because addition of these variables
did not alter the final effect estimate.
Time-fixed covariates included in the final model were age
and gender. Age at baseline was included in the model using
restricted quadratic splines with 3 knots, at 39, 52, and 65
years (40). Time-varying covariates included in the final
model were psychological stress (lagged 1 week), UV index
(not lagged), contact lens use (lagged 1week), time spent out-
doors (lagged 1, 2, and 3 weeks), and interactions between
UV index and lagged outdoor exposures. Weights were stabi-
lized by history of hours spent outdoors in each of the previ-
ous 3 weeks.
The resultant weights had a mean of 1.11 (standard devia-
tion, 2.33), with a range of 0.01–184.15 (Web Table 2).
Inverse-probability-of-exposure weights trimmed at 0.1 and
10 yielded weights with a mean of 1.01 (standard deviation,
0.67). Results using the trimmed weights are reported here
(41); use of the untrimmed weights produced similar results
(shown in Web Table 3). All analyses were conducted using
SAS 9.3 (SAS Institute Inc., Cary, North Carolina).
RESULTS
Table 1 presents data collected at study entry for 308 par-
ticipants in the nested substudy, who were followed for a me-
dian of 25 weeks. At study entry, participants had a median
age of 49 years; 48% were female, and 85% reported their
race as white. Compared with the entire population (n =
308), those who had an ocular HSV recurrence were slightly
older and less likely to have self-reported nonocular recur-
rences prior to study entry.
Table 2 presents data averaged over 10,163 ocular HSV
recurrence-free person-weeks of follow-up. In most of the
person-weeks, observed participants reported spending ≤7
unprotected hours outdoors. Use of glasses and sunglasses
was frequent, with 80% of participants reporting using them
on a regular basis. There were few differences between the
weeks in which participants reported spending 7 or fewer
hours outdoors and those in which they reported spending
8 or more hours outdoors. In total, there were 44 recurrences
of ocular HSV, yielding an incidence rate of 4.3 events per
1,000 person-weeks. Of the 308 participants, 159 (52%) were
censored after more than 3 weeks of missing reports (Web
Figure 1).
From our crude additive Poisson model, when comparing
weeks with≥8 hours outdoors with weeks with≤7 hours out-
doors, we estimated an incidence difference of −0.50 cases
per 1,000 person-years (95% CI: −2.01, 1.01) during weeks
with a UV index less than 4 and 3.73 cases per 1,000 person-
years (95% CI: 2.98, 4.48) during weeks with a UV index of
4 or higher.
The weighted Kaplan-Meier curves for ocular HSV recur-
rence according to UV index, pooled over all 30 imputations
(equivalent to taking the mean value), are shown in Figure 1
(crude Kaplan-Meier curves are shown in Web Figure 2). For
the weighted analysis, in the weeks where the UV index was
less than 4, the incidence of ocular HSV recurrence at 60
weeks was 23% for persons exposed to ≤7 hours outdoors
and 22% for persons exposed to ≥8 hours outdoors. In the
weeks where the UV index was 4 or higher, the incidence
of ocular HSV recurrence at 60 weeks was 13% for those
exposed to ≤7 hours outdoors and 46% for those exposed
to ≥8 hours.
Table 3 shows estimated hazard ratios for ocular HSV re-
currence due to sunlight exposure.Within levels of UV index,
we estimated crude hazard ratios of 0.81 (95% CI: 0.27, 2.41)
and 2.42 (95% CI: 1.00, 5.84) for weeks with a UV index of
<4 and ≥4, respectively (ratio of hazard ratios = 2.99, 95%
CI: 0.42, 21.4). Hazard ratios from a marginal structural
Cox model that accounted for potential confounding by
time-varying psychological stress and contact lens use and
for baseline age and gender were 0.84 (95% CI: 0.27, 2.63)
and 3.10 (95% CI: 1.14, 8.48), comparing ≥8 hours spent
outdoors with ≤7 hours, for weeks with UV indices of <4
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and ≥4, respectively (ratio of hazard ratios = 3.68, 95% CI:
0.43, 31.4).
The test of proportional hazards yieldedP values of 0.50 and
0.12 for the crude results and 0.47 and 0.10 for the inverse-
probability-of-treatment-and-censoring-weighted model for
UV indices of <4 and ≥4, respectively. The hazard ratio for
ocular HSV recurrence weakened over time. For instance, be-
tween randomization and 29 weeks, the marginal structural
model hazard ratios for ocular HSV recurrence were 1.01
(95% CI: 0.14, 7.38) and 6.49 (95% CI: 1.40, 30.1) for weeks
with UV indices of <4 and ≥4, respectively, while the hazard
ratios for ocular HSV recurrence between 30 and 65 weeks
were 0.78 (95% CI: 0.20, 3.12) and 1.41 (95% CI: 0.36,
5.52) for weeks with UV indices of <4 and ≥4, respectively.
When restricted to the 155 participants who were random-
ized to receive acyclovir treatment (who experienced 23
events), similar patterns of crude hazard ratios comparing
≥8 hours outdoors with ≤7 hours outdoors were observed.
The crude hazard ratio for weeks with a UV index less than
4 was 0.74 (95% CI: 0.16, 3.36), and for weeks with a UV
index of 4 or higher, it was 5.07 (95% CI: 1.34, 19.2). In
the weighted model, results for the same groups were 1.10
(95% CI: 0.24, 5.02) and 7.57 (95% CI: 1.91, 30.1), respec-
tively. Among the 153 persons who were randomized to re-
ceive placebo, results for the same groups from the crude and
weighted models were 0.85 (95% CI: 0.16, 4.41) and 0.97
(95% CI: 0.26, 4.07), respectively, and 0.65 (95% CI: 0.11,
3.74) and 0.86 (95% CI: 0.18, 4.16), respectively.
DISCUSSION
Because the HEDS analysis did not appropriately adjust
for time-varying psychological stress or contact lens use,
we expected to observe a different hazard ratio for ocular
HSV recurrence attributable to sunlight exposure.While mar-
ginal structural models were indicated since we suspected
time-varying confounding, we found little evidence of time-
varying confounding, as shown by the similar effect estimates
from the crude and weighted models.
Similarly, we expected to see a stronger relationship be-
tweensunlight exposureand recurrencewhenUVindexvalues
were higher and when we accounted for effect modification
by UV exposure.We did find a stronger estimate for the effect
of sunlight exposure on ocular HSV recurrence when the UV
index was ≥4, but our results were imprecise.
There are many ways that UV exposure is thought to im-
pact HSV recurrence; we review 2 possible mechanisms
here. The first pathway is depression of immune response
due to UV exposure. UV radiation has been shown to sup-
press HSV antigen presentation in epidermal cells (42) and
lead to the reduction of type 1 cytokine release (43), an im-
portant part of immunological control for viruses such as
Table 1. Baseline Characteristics of All Participants and Participants Who Experienced a Recurrence of Ocular
Herpes Simplex Virus, Herpetic Eye Disease Study, 1993–1997
Characteristic
All Participants (n = 308) Participants With Ocular HSV
Recurrence (n = 44)
No. % Median (IQR) No. % Median (IQR)
Age at randomization, years 49 (37–63) 54 (38–65)
Female gender 147 48 22 50
Race/ethnicity
White 263 85 41 93
African-American 20 6 1 2
Othera 25 8 2 5
Acyclovir treatment group 155 50 23 52
Study center location
New Orleans, Louisiana 33 11 5 11
Houston, Texas 21 7 2 5
San Francisco, California 61 20 5 11
Atlanta, Georgia 66 21 10 23
Chicago, Illinois 44 14 8 18
Milwaukee, Wisconsin 37 12 6 14
Philadelphia, Pennsylvania 21 7 6 14
New York, New York 25 8 2 5
No. of prior HSV recurrencesb
Ocular 4 (1–5) 3 (2–6)
Nonocular 5 (0–11) 0 (0–9)
Abbreviations: HSV, herpes simplex virus; IQR, interquartile range.
a Includes persons who reported their race/ethnicity as Asian (2 cases, 18 in total) or Hispanic (no cases, 7 in total).
b Numbers of prior recurrences of HSV were self-reported at study enrollment.
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HSV. Garssen et al. (44) extrapolated from an animal model
that exposure to 100 minutes of sunlight around noon on a
clear summer day in a southernMediterranean country would
lead to a 50% suppression in the T-cell response to a microbe.
This localized immunosuppression may allow sufficient viral
replication to cause a recurrence. The second pathway by
which UV radiation may affect recurrence is directly through
HSV reactivation. Cell repair, through the c-Jun and c-Fos
Table 2. Distribution of Person-Weeks During the Entire Follow-up Period and According to Self-reported Sun Exposure, Herpetic Eye Disease
Study, 1993–1997
Characteristic
Total Follow-up (10,163 PW)
Reported Sun Exposure, hours/week
≤7 (7,169 PW) ≥8 (2,994 PW)
No. % Median (IQR) No. % Median (IQR) No. % Median (IQR)
Age at randomization, years 52 (39–65) 52 (40–66) 49 (36–63)
Female gender 4,822 47 3,616 50 1,206 40
Race/ethnicity
White 8,933 88 6,350 89 2,583 86
African-American 565 6 382 5 183 6
Othera 665 6 437 6 228 8
Acyclovir treatment group 5,337 53 3,708 52 1,629 54
Study center location
New Orleans, Louisiana 955 9 655 9 300 10
Houston, Texas 755 7 616 9 139 5
San Francisco, California 1,929 19 1,253 17 676 23
Atlanta, Georgia 1,878 18 1,383 19 495 17
Chicago, Illinois 1,560 15 1,046 15 514 17
Milwaukee, Wisconsin 1,525 15 1,062 15 463 15
Philadelphia, Pennsylvania 697 7 517 7 180 6
New York, New York 864 9 637 9 227 8
Current use of contact lensesb 1,024 10 787 11 237 8
Use of glasses/sunglasses
while outsideb
8,037 79 5,631 79 2,406 80
Overall stress levelb,c
1 (lowest) 2,525 25 1,696 24 829 28
2 2,073 20 1,424 20 649 22
3 2,140 21 1,539 21 601 20
4 1,667 16 1,210 17 457 15
5 1,005 10 750 10 255 9
6 493 5 350 5 143 5
7 (highest) 260 3 200 3 60 2
Ultraviolet light index 4.5 (2.4–6.5) 3.9 (2.1–6.2) 5.5 (3.3–7.0)
Time spent outdoors,
hours/weekb
≤7 7,169 71 7,169 100 0 0
8–14 1,742 17 0 0 1,742 58
15–21 668 7 0 0 668 22
22–28 265 3 0 0 265 9
≥29 319 3 0 0 319 11
Abbreviations: IQR, interquartile range; PW, person-weeks.
a Includes personswho reported their race/ethnicity as Asian (384 in total, 236 for≤7 hours/week, and 148 for≥8 hours/week) or Hispanic (281 in
total, 201 for ≤7 hours/week, and 80 for ≥8 hours/week).
b Before datawere carried forward, the following amounts of dataweremissing (percentage of weeks prior to recurrence, dropout, or end of study
period): for use of contact lenses, 20.3%; for use of glasses/sunglasses, 26.7%; for overall stress, 21.5%; and for time spent outdoors, 20.1%.
c Stress was measured by asking, “In the past week, how stressed have you felt overall?” Participants could answer on a 7-point Likert scale.
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transcription factors, activates the HSV transcription pro-
moter (infected cell polypeptide 0), leading to HSV transcrip-
tion and reactivation (45). Additionally, these repair pathways
circumvent the activity of HSV latency-associated transcript,
which prevents infected neurons from undergoing apoptosis
(46), in turn reactivating HSV. Given the proposed mecha-
nisms for interaction of UV light with HSV recurrence, it be-
comes clear that looking for seasonal trends in recurrence or
relating recurrences to time spent outdoors would probably
not capture an individual’s exposure. While our assessment
of UV exposure was more specific than that of previous stud-
ies, other methods (e.g., a UV dosimeter) would more finely
delineate exposure.
There were limitations to this research. We assumed no
unmeasured confounding and no informative censoring by
unmeasured factors; if either of these assumptions were not
met, our hazard ratios would be biased. In particular, psycho-
logical stress is a difficult quantity to reliably measure and
may not have been well captured in this study. Second, the
results from this nested cohort study may not be generalizable
to a target population of persons with ocular HSV disease,
who may differ in composition from trial population samples
(47, 48), which are often highly selective. Third, 51% of the
participants were censored after not completing 3 weekly
logs in a row. Sensitivity analysis for time-varying missing
data could be undertaken but was beyond the scope of this
study. Fourth, while use of a fuller account of the covariate
histories, a less restrictive functional form for age and time
in the study, and a broader set of covariates (e.g., region, sys-
temic illness, acyclovir treatment) did not appreciably alter
our results, there could have been model misspecification.
Fifth, because biological samples were not collected in
HEDS, we were unable to assess the effect of UV exposure
on viral shedding, an important component of HSV transmis-
sion. Sixth, we assumed positivity (49), that is, a nonzero
probability of exposure at every level of the observed con-
founders in the population.
Figure 1. Weighted Kaplan-Meier estimates of the cumulative risk of
ocular herpes simplex virus recurrence among 308 participants in the
Herpetic Eye Disease Study during person-weeks with an ultraviolet
index value of ≥4 (top) or <4 (bottom), 1993–1997. Results were
pooled over 30 imputations. Solid line, high sunlight exposure (≥8
hours/week); dashed line, low sunlight exposure (≤7 hours/week).
Table 3. Estimated Effect of Sunlight andUltraviolet Light Exposure
(UV Index) on Time to Recurrence of Ocular Herpes Simplex Virus

















≤7 27 7,169 1
≥8 17 2,994 1.46 0.79, 2.68
UV index <4
≤7 18 3,619 1
≥8 4 949 0.81 0.27, 2.41
UV index ≥4
≤7 9 3,550 1
≥8 13 2,045 2.42 1.00, 5.84
Weighted Model b
Total
≤7 27 7,169 1
≥8 17 2,994 1.85 0.89, 3.88
UV index <4
≤7 18 3,619 1
≥8 4 949 0.84 0.27, 2.63
UV index ≥4
≤7 9 3,550 1
≥8 13 2,045 3.10 1.14, 8.48
Abbreviation: UV, ultraviolet.
a 95% confidence intervals for results stratified by UV index were
calculated using robust methods to account for variance between
imputations.
b The weighted model accounted for time-varying psychological
stress and use of contact lenses and for baseline age and gender.
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Last, we assumed consistency and its practical implication
of irrelevance of exposure variation (in this case, time spent
outdoors) (50). This assumption was the most problematic
here. Participants may have experienced their time spent out-
doors differently (e.g., time spent outside in the early morn-
ing hours might be different from that spent during the
afternoon). Additionally, an intervention designed to restrict
persons who usually spend≥8 hours per week outdoors to≤7
hours per week would have to mimic the distribution of ex-
posures found in the ≤7-hour group in order to produce an
effect estimate similar to ours (51). However, we improved
upon previous work by including UV index data to decrease
unquantified exposure variation.
There were several strengths of this research. Recurrences
of ocular HSV were well documented and were confirmed by
study-trained physicians. The use of prospective data helped
ensure the proper temporal order between exposures, con-
founders, and ocular HSV recurrences. Exclusion of weekly
reports completed tardily minimized recall bias (29). The use of
time-updated reports reduced bias due to measurement error
(52). Use of modern methods that allow feedback offered us
an opportunity to disentangle the relationship between UV
light and stress. Randomization to a certain number of hours
spent outdoors may be difficult to implement and would
likely have low compliance. Without randomized evidence,
a thorough analysis of prospective observational data with
repeated measures provides the best estimates of etiological
effects.
Findings from this and further research could guide clini-
cians in recommending behavioral interventions for persons
with ocular HSV. Physicians could recommend restriction of
a patient’s time outdoors during peak hours of UV exposure
on days with a high UV index. Another possible route for
prevention of recurrence would be the use of UV-blocking
sunglasses—although many of the participants in this study
did wear some type of glasses, so perhaps a brimmed hat or
glasses with particularly strong UV protection should be con-
sidered. Our results, though imprecise, do not suggest an
effect of acyclovir on UV-induced recurrences; however, fur-
ther research on this relationship is warranted.
In conclusion, we found an association between increased
time spent outdoors and the risk of ocular HSV recurrence
when the UV index was relatively high. Further research is
needed both to replicate these results and to explore more
finely the UV exposure associated with increased risk of
HSV recurrence.
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